Advertisement Mindray Medical Q4 net income rises - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Mindray Medical Q4 net income rises

Mindray Medical International, a developer, manufacturer and marketer of medical devices, has reported that GAAP net income was $31.6 million, or $0.28 per diluted share, for the fourth quarter of 2008, compared to $21.5 million, or $0.19 per diluted share, in the fourth quarter of 2007.

For the year 2008, GAAP net income was $108.7 million, or $0.96 per diluted share, compared to $78 million, or $0.69 per diluted share, in 2007.

Mindray reported net revenues of $167.9 million for the fourth quarter of 2008, an 84.2% increase from $91.1 million for the fourth quarter of 2007. The company recorded net revenues of $547.5 million for the year 2008, an 86% increase from $294.3 million for the year 2007.

Xu Hang, Mindray’s chairman and co-CEO, said: “Mindray has continued to deliver strong results despite a challenging economic environment in the fourth quarter of 2008. In 2008, we successfully completed and delivered initial synergy targets from the acquisition of Datascope’s patient monitoring business which greatly expanded our geographic footprint in North America and strengthened our presence in Europe.”